Kapadia Sandip
SEC CIK 1677141 · EDGAR
BoughtSold
Most active insiders at HRMY, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Budur Kumar | Chief MEDICAL Off | — | $3.11M |
| 2 | Kapadia Sandip | CFO | — | $1.80M |
| 3 | Dayno Jeffrey M. | Pres, CEO, Dir | — | $1.04M |
| 4 | Zaeske Adam H. | Chief COMMERCIAL Off | — | — |
| 5 | Serafin Andrew | Chief STRATEGY Off | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-28 | 2026-01-26 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale | $37.15 | -3,746 | 24.5K | -13% | -$139.2K | |
| DM | 2026-01-26 | 2026-01-24+ | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $0.00 | +8,538 | 3,813 | New | $0 |
| DM | 2026-01-26 | 2026-01-24+ | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | F - Tax | $36.82 | -4,792 | 1,574 | -75% | -$176.4K |
| 2026-01-20 | 2026-01-15 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale | $35.92 | -21.0K | 0 | -100% | -$752.9K | |
| D | 2025-12-09 | 2025-12-05 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $29.03 | +20.0K | 20.0K | New | +$580.6K |
| D | 2025-12-09 | 2025-12-05 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale+OE | $39.54 | -20.0K | 0 | -100% | -$790.8K |
| 2025-11-25 | 2025-11-21 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale | $35.00 | -3,427 | 0 | -100% | -$119.9K | |
| D | 2025-10-02 | 2025-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $0.00 | +45.0K | 45.0K | New | $0 |
| D | 2025-10-02 | 2025-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | F - Tax | $27.56 | -24.0K | 21.0K | -53% | -$662.5K |
| 2025-08-19 | 2025-08-15 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale | $36.50 | -21.6K | 0 | -100% | -$787.4K | |
| M | 2025-04-03 | 2025-04-01 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale | $32.55 | -6,987 | 0 | -100% | -$227.4K |
| D | 2025-04-01 | 2025-03-29 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | F - Tax | $33.19 | -8,014 | 6,986 | -53% | -$266.0K |
| D | 2025-04-01 | 2025-03-29 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $0.00 | +15.0K | 15.0K | New | $0 |
| D | 2025-01-28 | 2025-01-27 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale+OE | $38.05 | -1,775 | 0 | -100% | -$67.5K |
| D | 2025-01-28 | 2025-01-24 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | F - Tax | $38.01 | -2,037 | 1,775 | -53% | -$77.4K |
| D | 2025-01-28 | 2025-01-24 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $0.00 | +3,812 | 3,812 | New | $0 |
| D | 2025-01-23 | 2025-01-21 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $29.03 | +25.0K | 25.0K | New | +$725.8K |
| D | 2025-01-23 | 2025-01-21 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | S - Sale+OE | $40.18 | -25.0K | 0 | -100% | -$1.00M |
| D | 2024-10-02 | 2024-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | F - Tax | $40.00 | -32.1K | 27.9K | -53% | -$1.28M |
| D | 2024-10-02 | 2024-09-30 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $0.00 | +60.0K | 60.0K | New | $0 |
| D | 2024-04-02 | 2024-03-29 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | F - Tax | $33.58 | -8,013 | 6,987 | -53% | -$269.1K |
| D | 2024-04-02 | 2024-03-29 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $0.00 | +15.0K | 15.0K | New | $0 |
| D | 2023-03-31 | 2023-03-29 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | F - Tax | $33.36 | -15.4K | 14.6K | -51% | -$514.2K |
| D | 2023-03-31 | 2023-03-29 | HRMY | Harmony Biosciences Holdings, Inc. | Kapadia Sandip | CFO | M - OptEx | $0.00 | +30.0K | 30.0K | New | $0 |
| 2022-12-02 | 2022-12-01 | PASG | Passage BIO, Inc. | Kapadia Sandip | Dir | S - Sale | $1.19 | -5,000 | 0 | -100% | -$5,950 |
Purchase Sale Sale after option exercise All abbreviations